Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs

Go back to Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
(NASDAQ: IMTX) Delayed: 9.34 -0.18 (1.89%)
Previous Close $9.52    52 Week High
Open $9.33    52 Week Low
Day High $9.73    P/E N/A 
Day Low $9.32    EPS
Volume 110,327